Enter the world of peripheral Drug Elution
Case study: using DCB and DES in polystenotic calcified right SFA in a 75-year old male patient
Treatment options in PAD: catching up with coronary
Having worked together on a case study Thomas Zeller, Koen Deloose and Jay Kokate discuss with Max Amor the PAD treatment options available today.
If you are interested in knowing more about Drug-Eluting Technologies, read Prof. Müller-Hülsbeck’s Expert Opinion article below:
Download here: Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee. Prof. Stefan Müller-Hülsbeck.
Endovascular approaches for treating stenotic lesions of the peripheral arteries located above the knee (i.e. superficial femoral [SFA] and proximal popliteal arteries) invariably include the positioning of stents. However, the challenging biological environment means that restenosis or occlusion of the treated territory occur frequently requiring reintervention. The EluviaTM drug-eluting stent is designed to sustainably deliver an antiproliferative agent directly to the arterial tissue exactly when and where it is needed to reduce the incidence of restenosis.